|
19 Companies |
|
16 Products |
|
16 Products |
|
19 Mechanisms of Action |
|
2 Trials |
|
524 News |
|
| «1234567891011» |
- | Trial completion: Clinical Trial for the Treatment of Diabetic Foot Ulcers Using a Nitric Oxide Releasing Patch: PATHON (clinicaltrials.gov) - Nov 1, 2012
P3, N=100, Completed, Sponsor: Fundaci
Active, not recruiting --> Completed
- | metformin / Generic mfg.
New P2 trial: BA/BE 199/11: BE STUDY OF METFORMIN GSK 1000mg (clinicaltrials.gov) - Oct 17, 2012
P2, N=32, Completed, Sponsor: GlaxoSmithKline
- | metformin / Generic mfg.
New P2 trial: BA/BE 198/11: BE Study of Metformin GSK 850mg (clinicaltrials.gov) - Oct 17, 2012
P2, N=32, Completed, Sponsor: GlaxoSmithKline
- | metformin / Generic mfg.
New P2 trial: BA/BE 173/11: BE Study of Metformin GSK 500mg (clinicaltrials.gov) - Oct 17, 2012
P2, N=32, Completed, Sponsor: GlaxoSmithKline
- Trial completion: VUTEF: Venous Ulcer Treatment With Foam Versus Conservative Treatment (clinicaltrials.gov) - Sep 29, 2012
P=N/A, N=46, Completed, Sponsor: Hospital Occidente de Kennedy
Active, not recruiting --> Completed Recruiting --> Completed
- | Trial completion, Metastases: THERMES ET VEINES: Spa for Prevention of Leg Ulcers (clinicaltrials.gov) - Sep 27, 2012
P3, N=425, Completed, Sponsor: Association Francaise pour la Recherche Thermale
Recruiting --> Completed Active, not recruiting --> Completed
- ||||||| Trial completion: Study to Evaluate the Performance of AQUACEL (clinicaltrials.gov) - Sep 17, 2012
P3, N=65, Completed, Sponsor: ConvaTec Inc.
Active, not recruiting --> Completed Recruiting --> Completed
- Enrollment open: Immune Response of Patients With Chronic, Staphylococcus Aureus-infected Wounds (clinicaltrials.gov) - Sep 16, 2012
P=N/A, N=76, Recruiting, Sponsor: Centre Hospitalier Universitaire de N?mes
Recruiting --> Completed Not yet recruiting --> Recruiting
- Trial withdrawal: DIPIOS: a Randomized Controlled Trial Comparing Medical and Medical-surgical Treatment in Diabetic Foot Osteomyelitis (clinicaltrials.gov) - Sep 13, 2012
P4, N=0, Withdrawn, Sponsor: Assistance Publique - H
Not yet recruiting --> Recruiting Recruiting --> Withdrawn
- Enrollment change: Comparative Study of Amniotic Membrane Wound Graft In the Management of Diabetic Foot Ulcers (clinicaltrials.gov) - Sep 13, 2012
P=N/A, N=25, Completed, Sponsor: MiMedx Group, Inc.
Recruiting --> Withdrawn N=40 --> 25
- Enrollment change: DIPIOS: a Randomized Controlled Trial Comparing Medical and Medical-surgical Treatment in Diabetic Foot Osteomyelitis (clinicaltrials.gov) - Sep 13, 2012
P4, N=0, Withdrawn, Sponsor: Assistance Publique - H
N=40 --> 25 N=146 --> 0
- | Trial completion: Comparative Study of Amniotic Membrane Wound Graft In the Management of Diabetic Foot Ulcers (clinicaltrials.gov) - Sep 13, 2012
P=N/A, N=25, Completed, Sponsor: MiMedx Group, Inc.
N=146 --> 0 Recruiting --> Completed
- Enrollment change: A Clinical Study of the Safety and Efficacy of MEBO (clinicaltrials.gov) - Aug 22, 2012
P2, N=7, Completed, Sponsor: Skingenix, Inc.
Recruiting --> Completed N=14 --> 7
- Enrollment change: A Clinical Study of the Safety and Efficacy of MEBO Wound Ointment in Subjects With Venous Leg Ulcers (clinicaltrials.gov) - Aug 22, 2012
P2, N=5, Completed, Sponsor: Skingenix, Inc.
N=14 --> 7 N=14 --> 5
- Clinical: Olivamine-containing Products in the Management of Patients With Nonhealing Lower Extremity Ulcers (clinicaltrials.gov) - Aug 2, 2012
P=N/A, N=50, Not yet recruiting, Sponsor: De La Salle University Medical Center
- |||||||||| New P3 trial: Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers (clinicaltrials.gov) - Aug 1, 2012
P3, N=440, Active, not recruiting, Sponsor: Healthpoint
- |||| Trial completion: Comparative Study of 3 Dose Regimens of BioChaperone to Becaplermin Gel for the Treatment of Diabetic Foot Ulcer (clinicaltrials.gov) - Jul 31, 2012
P1/2, N=192, Completed, Sponsor: Virchow Group
N=14 --> 5 Recruiting --> Completed
- Biomarker: Research of Prognostic Factors Associated With Healing of Venous Leg Ulcers (clinicaltrials.gov) - Jul 30, 2012
P=N/A, N=104, Completed, Sponsor: Centre Hospitalier Universitaire, Amiens
- Trial completion: Polydeoxyribonucleotide -Placentex Mastelli(Pdrn) for the Treatment of Diabetic Ulcers (clinicaltrials.gov) - Jul 30, 2012
P4, N=215, Completed, Sponsor: University of Messina
Recruiting --> Completed Recruiting --> Completed
- LeukoScan (sulesomab) / Gilead
Enrollment open: ISEOD: PET/CT Scanning for the Follow-up of Antibiotic Treatment of Infectious Osteoarthritis in the Diabetic Foot (clinicaltrials.gov) - Jul 25, 2012
P=N/A, N=109, Recruiting, Sponsor: Centre Hospitalier Universitaire de N?mes
Recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment change: The Foot in Your Nose Study: Links Between Nasal Staphylococcus Aureus Colonies and Diabetic Foot Lesion Infections (clinicaltrials.gov) - Jul 24, 2012
P=N/A, N=278, Completed, Sponsor: Centre Hospitalier Universitaire de N?mes
Not yet recruiting --> Recruiting N=401 --> 278
- Trial completion: The Foot in Your Nose Study: Links Between Nasal Staphylococcus Aureus Colonies and Diabetic Foot Lesion Infections (clinicaltrials.gov) - Jul 24, 2012
P=N/A, N=278, Completed, Sponsor: Centre Hospitalier Universitaire de N?mes
N=401 --> 278 Recruiting --> Completed
- Trial termination: A Comparison of an Investigational Dressing to Tegaderm Matrix Wound Dressing in the Management of Diabetic Foot Ulcers (clinicaltrials.gov) - Jul 22, 2012
P=N/A, N=43, Terminated, Sponsor: 3M
Recruiting --> Completed Recruiting --> Terminated; Expired study materials; low subject recruitment
- Enrollment change: A Comparison of an Investigational Dressing to Tegaderm Matrix Wound Dressing in the Management of Diabetic Foot Ulcers (clinicaltrials.gov) - Jul 22, 2012
P=N/A, N=43, Terminated, Sponsor: 3M
Recruiting --> Terminated; Expired study materials; low subject recruitment N=150 --> 43
- ||| Trial initiation date: A Study to Investigate the Safety and Clinical Effect of Nexagon (clinicaltrials.gov) - Jul 18, 2012
P2, N=168, Completed, Sponsor: CoDa Therapeutics Inc.
N=150 --> 43 Initiation date: Feb 2012 --> Jul 2012
- ||| Clinical: A Prospective, Randomized, Double-Blind Multicenter Study Comparing Continuous Diffusion of Oxygen (CDO) Therapy to Standard Moist Wound Therapy (MWT) in the Treatment of Diabetic Foot Ulcers (clinicaltrials.gov) - Jul 18, 2012
P=N/A, N=110, Recruiting, Sponsor: Electrochemical Oxygen Concepts, Inc.
- | Trial termination: Silica Gel Fiber Wound Dressing for Chronic Venous Leg Ulcers (clinicaltrials.gov) - Jul 15, 2012
P2, N=126, Terminated, Sponsor: Bayer
Initiation date: Feb 2012 --> Jul 2012 Completed --> Terminated
- ||||| Enrollment closed: Efficacy and Safety of rhEGF in Diabetic Foot Ulcer Patients With Uncontrolled Diabetic Mellitus (clinicaltrials.gov) - Jul 11, 2012
P3, N=176, Active, not recruiting, Sponsor: Daewoong Pharmaceutical Co. LTD.
Completed --> Terminated Recruiting --> Active, not recruiting
- New P3 trial: August2: Safety and Efficacy Study of Urokinase for the Treatment of Diabetic Foot Syndrome and Critical Limb Ischemia (clinicaltrials.gov) - Jul 9, 2012
P3, N=34, Terminated, Sponsor: GWT-TUD GmbH
- |||||||||| New P3 trial: Efficacy and Safety of rhEGF in Diabetic Foot Ulcer Patients With Uncontrolled Diabetic Mellitus (clinicaltrials.gov) - Jun 25, 2012
P3, N=176, Active, not recruiting, Sponsor: Daewoong Pharmaceutical Co. LTD.
- Enrollment change: Feasibility Study to Evaluate the Safety of Topically Applied Revera in Subjects With Venous Leg Ulcers (clinicaltrials.gov) - Jun 21, 2012
P1, N=13, Completed, Sponsor: Revalesio Corporation
Recruiting --> Active, not recruiting N=24 --> 13
- | Trial completion: Feasibility Study to Evaluate the Safety of Topically Applied Revera in Subjects With Venous Leg Ulcers (clinicaltrials.gov) - Jun 21, 2012
P1, N=13, Completed, Sponsor: Revalesio Corporation
N=24 --> 13 Active, not recruiting --> Completed
- New P4 trial: RESPOND Restoring Equilibrium and Wound Stimulation to Promote Healing Of Non-healing DFUs (clinicaltrials.gov) - May 29, 2012
P4, N=13, Terminated, Sponsor: Celleration, Inc.
- ||| Enrollment open: Effects of Non Contact Low Frequency Ultrasound in Healing Venous Leg Ulcers (clinicaltrials.gov) - May 28, 2012
P=N/A, N=208, Recruiting, Sponsor: Celleration, Inc.
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- |||| Enrollment open: Efficacy Study of IZN-6D4 Gel for the Treatment of Diabetic Foot Ulcers (clinicaltrials.gov) - May 22, 2012
P2, N=80, Recruiting, Sponsor: Izun Pharma Ltd
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- ||||| Grafix (cryopreserved placental membrane) / Osiris
New P4 trial: Grafix (clinicaltrials.gov) - May 9, 2012
P4, N=97, Completed, Sponsor: Osiris Therapeutics
- |||||||||| Locilex (pexiganan acetate) / PLx Pharma
New P3 trial, Head-to-Head: OneStep-2: Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers (clinicaltrials.gov) - May 7, 2012
P3, N=180, Not yet recruiting, Sponsor: Dipexium Pharmaceuticals, LLC
- |||||||||| New P3 trial: Study to Evaluate the Performance of AQUACEL (clinicaltrials.gov) - May 2, 2012
P3, N=65, Completed, Sponsor: ConvaTec Inc.
- |||||||||| Locilex (pexiganan acetate) / PLx Pharma
New P3 trial, Head-to-Head: OneStep-1: Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers (clinicaltrials.gov) - May 1, 2012
P3, N=180, Not yet recruiting, Sponsor: Dipexium Pharmaceuticals, LLC
- Enrollment open: SAS-FOOT: Impact of Sleep Apnea on Diabetic Foot Wound. (clinicaltrials.gov) - May 1, 2012
P=N/A, N=60, Recruiting, Sponsor: AGIR
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- New P3 trial: SANIBA: Off- Loading Shoe to Improve Healing and Prevention of Recurrence of Neuropathic Diabetic Plantar Foot Ulcers (clinicaltrials.gov) - Apr 24, 2012
P3, N=33, Completed, Sponsor: Assistance Publique - H
- | Trial completion: EASH Dressing on Chronic Venous Leg Ulcers (clinicaltrials.gov) - Apr 23, 2012
P2, N=40, Completed, Sponsor: ConvaTec Inc.
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Clinical: Dynamic Plantar Microvascular Skin Response to Compressive Loads in At-risk Diabetic and Healthy Control: a Pilot Study (clinicaltrials.gov) - Apr 16, 2012
P=N/A, N=50, Recruiting, Sponsor: Temple University
- | New P4 trial: Wound Fluid Protease Levels During Use of Novel Wound Dressing (clinicaltrials.gov) - Mar 28, 2012
P4, N=30, Recruiting, Sponsor: Hollister Incorporated
- Trial completion: Treatment of Cutaneous Ulcers With a Novel Biological Dressing (clinicaltrials.gov) - Mar 26, 2012
P1/2, N=6, Completed, Sponsor: Centre Hospitalier Universitaire de Qu
Active, not recruiting --> Completed Recruiting --> Completed
- Cubicin (daptomycin) / Merck (MSD)
Trial termination: Application of Daptomycin in MRSA Infected Diabetic Foot in Comparison to Vancomycin Treatment (clinicaltrials.gov) - Mar 25, 2012
P3, N=1, Terminated, Sponsor: Ruhr University of Bochum
Recruiting --> Completed Recruiting --> Terminated; Patient number to be enrolled not reachable in prospected time frame, decision to stop the study prematurely was made.
- Cubicin (daptomycin) / Merck (MSD)
Enrollment change: Application of Daptomycin in MRSA Infected Diabetic Foot in Comparison to Vancomycin Treatment (clinicaltrials.gov) - Mar 25, 2012
P3, N=1, Terminated, Sponsor: Ruhr University of Bochum
Recruiting --> Terminated; Patient number to be enrolled not reachable in prospected time frame, decision to stop the study prematurely was made. N=120 --> 1
- | Trial completion: Evaluation of Negative Pressure Wound Therapy in the Treatment of DFUs Incl. Post Amputation Wounds. (clinicaltrials.gov) - Mar 19, 2012
P=N/A, N=16, Completed, Sponsor: Molnlycke Health Care AB
N=120 --> 1 Recruiting --> Completed
- ||| Enrollment open: Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers (clinicaltrials.gov) - Mar 18, 2012
P=N/A, N=100, Recruiting, Sponsor: MiMedx Group, Inc.
Recruiting --> Completed Not yet recruiting --> Recruiting
- |||| Trial completion: A Dose Finding Study of Topically Applied I-020201 as an Adjunct to Good Standard-of-care in Patients With Chronic Diabetic Foot Ulcers (clinicaltrials.gov) - Mar 14, 2012
P2, N=211, Completed, Sponsor: Kuros Biosurgery AG
Not yet recruiting --> Recruiting Active, not recruiting --> Completed